|
|
|
|
Дата |
|---|
| 15.07.2026 |
| 14.07.2026 |
| 13.07.2026 |
| 10.07.2026 |
| 09.07.2026 |
| 08.07.2026 |
| 07.07.2026 |
| 06.07.2026 |
| 03.07.2026 |
| 02.07.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
50.62
|
47.73
|
50.62
|
50.62
|
|
|
2 190 577 641.00
|
|
|
|
|
43.11
|
40.01
|
46.43
|
46.02
|
|
|
2 997 726 247.00
|
|
|
|
|
44.12
|
42.75
|
46.85
|
43.01
|
|
|
3 035 555 716.00
|
|
|
|
|
38.65
|
38.64
|
43.22
|
43.22
|
|
|
2 273 105 195.00
|
|
|
|
|
37.80
|
37.28
|
40.17
|
39.29
|
|
|
1 068 893 702.00
|
|
|
|
|
39.23
|
37.66
|
40.32
|
37.90
|
|
|
1 130 191 740.00
|
|
|
|
|
40.30
|
38.66
|
40.77
|
39.23
|
|
|
1 394 315 212.00
|
|
|
|
|
39.80
|
39.22
|
43.58
|
41.24
|
|
|
1 959 906 659.00
|
|
|
|
|
40.33
|
38.85
|
40.66
|
40.56
|
|
|
1 236 615 033.00
|
|
|
|
|
40.45
|
39.51
|
42.50
|
39.62
|
|
|
1 441 349 108.00
|
|
Период |
|---|
| 2025, регулярные |
| 2024, регулярные |
| 2023, регулярные |
| 2022, регулярные |
| 2021, регулярные |
| 2020, регулярные |
| 2019, регулярные |
| 2018, регулярные |
| 2017, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
30.06.2026
|
29.06.2026 |
0.12 CNY |
|
14.08.2025
|
13.08.2025 |
0.03 CNY |
|
31.07.2024
|
30.07.2024 |
0.16 CNY |
|
25.07.2023
|
24.07.2023 |
0.4 CNY |
|
08.08.2022
|
05.08.2022 |
0.36 CNY |
|
05.08.2021
|
04.08.2021 |
0.35 CNY |
|
08.06.2020
|
05.06.2020 |
0.34 CNY |
|
10.04.2019
|
09.04.2019 |
0.3 CNY |
|
31.05.2018
|
30.05.2018 |
0.3 CNY |
Joinn Laboratories (China) Co Ltd is a China-based company principally engaged in the provision of pharmaceutical research and development outsourcing services. The Company operates its business through two segments. The Pharmaceutical Research and Development Outsourcing Services segment mainly provides non-clinical safety evaluation services, pharmacodynamic research services, animal pharmacokinetic research services and drug screening services. The Laboratory Animal Production and Marketing segment is principally engaged in the production and sales of laboratory animals such as mice, rats and monkeys as well as their ancillary products.
